Dextrin-based hydrogel for the development of injectable bone substitute by Pereira, Isabel et al.
 21 
Dextrin-based hydrogel for the development of injectable bone substitute 
 
Pereira Ia, Simões Jb, Fraga Scd, Maltez Le, Evtuguin DVf, Domingues RMb, Coimbra MAb, Teixeira 
JPcd, Maurício ACg, Santos JDh, Muñoz Fi Pereira Je and Gama Ma 
 
aCEB - Centre of Biological Engineering, Universidade do Minho, 4710-057 Braga, Portugal 
bQOPNA, Department of Chemistry, University of Aveiro, 3810-193 Aveiro, Portugal 
cEnvironmental Health Department, National Institute of Health, 4000-053 Porto, Portugal 
dEPIUnit – Institute of Public Health, University of Porto, 4050-600 Porto, Portugal 
eDepartment of Veterinary Sciences, University of Trás-os-Montes e Alto Douro, 5001-801 Vila 
Real, Portugal 
fCICECO, Department of Chemistry, University of Aveiro, 3810-193 Aveiro, Portugal 
gICBAS, University of Porto, 4050-313, Porto, Portugal 
hBiosckin, Molecular and Cell Therapies, S.A., 4470-605 Maia, Portugal 
iDepartment of Veterinary Clinical Sciences, University of Santiago de Compostela, 27002 Lugo, 
Spain 
Group: FUNCARB | Line: Health Biotechnology and Bioengineering 
 
The development of injectable bone substitutes (IBS) have garnered great importance in the bone 
regeneration field, as a strategy to reach areas of the body using minimally invasive procedures, and 
showing the ability of perfect fitting according to irregularities of bone tissue defects. In this context, the 
combination of injectable hydrogels and ceramic granules is emerging as a well-established trend. 
Particularly, in situ gelation hydrogels have arisen as a new IBS generation.  
An injectable and in situ gelation hydrogel (HG) based on dextrin was developed aiming act as a carrier 
for bone graft granules and biomolecules [1] [2]. Dextrin is a low weight carbohydrate obtained by partial 
hydrolysis of starch that is already widely used in the cosmetic, textile and food industries. Furthermore, 
it is biocompatible, non-immunogenic and biodegradable, which renders dextrin a promising polymer 
for biomedical applications such as scaffolds and/or drug delivery systems.  
To prepare the HG, dextrin was firstly oxidized with sodium periodate (NaIO4) and then cross-linked with 
adipic acid dihydrazide, a non-toxic cross-linking molecule. Since HG will be a vehicle for medical 
application, a sterilization protocol for oxidized dextrin (ODEX) by gamma radiation was investigated, as 
well as, the effect of partial periodate oxidation effect on dextrin structure (oxidized derivatives), using 
mass spectrometry-based techniques. The results showed that gamma irradiation did not promote 
changes on the chemical structure of ODEX, and, so that, can be used as suitable terminal sterilization 
method for ODEX. In vitro cito- and genotoxicity assays performed in human lymphoblastoid TK6 cells 
revealed that HG displayed cytotoxicity depending on concentration, due to ODEX, but did not promote 
DNA damage. In vivo skin sentitization test showed that HG is not allergic.  
The HG combined with commercial ceramic granules (macroporous Bonelike®, 250-500 µm) was tested 
in pre-clinical trials using a goat model, in two different bone defects: critical-sized calvarial defect (14 
mm) and segmental tibial fracture (4 mm). The HG allowed the proper cohesion between the granules 
on the formulation and, also guaranteed mixture injectability. One the other hand, HG was able to 
stabilize in situ granules into the bone defects during tested periods (3-12 weeks) without affecting 
Bonelike® granules’ osteoconductive properties neither impairing the bone repair/regeneration process. 
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